ACR
Click for more information
1.39% 7.3¢ acrux limited

lilly to acquire global license to axiron, page-23

  1. SNI4
    509 Posts.
    clock Created with Sketch.
    16/03/10
    17:03
    Post #: 6456246
    $44n mil profit. 160 mil shares = PER around 8-9. That's fairly cheap.
    But if you're in for the long haul Axiron is the first step. There are numerous more drugs that can be licensed etc to be delivered by Acrux technology. Patches may become obsolete. It can be an option where tablets aren't suitable. If you're prepared to wait there can be big upside here or still takeover.
    ACR Price at posting: $2.43 Sentiment: None Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

BOT US FDA approves Botanix Pharma's excessive underarm sweat drug
right-arrow Created with Sketch.
RDN If you thought lithium was dead, think again. The Pilbara will be central to the next upswing
right-arrow Created with Sketch.
AML Cultural heritage agreement puts Walford Creek exploration back on the map
right-arrow Created with Sketch.
GYG Guzman Y Gomez shot up nearly 40% in first hour of trades. Can it last?
right-arrow Created with Sketch.
NEWS Microcap Madness: 5 junior explorers with news out on Thursday 20 June
right-arrow Created with Sketch.
GWR Scoping study and Phase 2 drilling progress Prospect Ridge magnesium play for GWR
right-arrow Created with Sketch.
watchlist Created with Sketch. Add ACR (ASX) to my watchlist
(20min delay)
Last
7.3¢ 		Change
0.001(1.39%) 		Mkt cap ! $21.22M
Open High Low Value Volume
7.1¢ 7.3¢ 7.1¢ $9.252K 127.8K

Buyers (Bids)

No. Vol. Price($)
1 75344 7.2¢
 

Sellers (Offers)

Price($) Vol. No.
7.3¢ 15232 1
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.